No Data
No Data
Aileron Therapeutics to Be Included in the Russell Microcap Index
AUSTIN, Texas, July 1, 2024 /PRNewswire/ -- Aileron Therapeutics, Inc. ("Aileron" or the "Company") (NASDAQ: ALRN), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines
Aileron Therapeutics(ALRN.US) 10% Shareholder Sells US$21,567.75 in Common Stock
$Aileron Therapeutics(ALRN.US)$ 10% Shareholder UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO sold 6,607 shares of common stock on Jun 14, 17, 2024 at an average price of $3.26 for a total val
Aileron Therapeutics(ALRN.US) 10% Shareholder Sells US$80,709.83 in Common Stock
$Aileron Therapeutics(ALRN.US)$ 10% Shareholder UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO sold 24,671 shares of common stock on Jun 10, 11, 12, 2024 at an average price of $3.271 for a tot
Aileron Therapeutics(ALRN.US) 10% Shareholder Sells US$40,528.3 in Common Stock
$Aileron Therapeutics(ALRN.US)$ 10% Shareholder UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO sold 12,315 shares of common stock on Jun 5, 6, 7, 2024 at an average price of $3.29 for a total v
Express News | Aileron Therapeutics Inc - on May 15 Appointed Timothy M. Cunningham as Interim Chief Financial Officer, Effective as of May 16
Express News | Aileron Therapeutics Inc: Expects Its Existing Cash and Cash Equivalents to Fund Operations Into Second Half of 2025.
No Data